Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Gentile

Showing results (111-120 of 313) with videos related to

Pageof 32
Sort By:
Leukemia & Lymphoma|July 21, 2005
A gender-based score system predicts the clinical outcome of patients with early B-cell chronic lymphocytic leukemiaStefano Molica, Francesca R Mauro, Vincenzo Callea, et al.
Expert Review of Hematology|June 25, 2025
Maintenance therapy after ASCT in newly diagnosed multiple myeloma patients: single agent <i>versus</i> combination drugsEnrica Antonia Martino, Ernesto Vigna, Caterina Labanca, et al.
European Journal of Haematology|December 26, 2025
Chemotherapy-Sparing Strategies in Follicular Lymphoma: Emerging Targeted and Immune-Based ApproachesEnrica Antonia Martino, Santino Caserta, Mamdouh Skafi, et al.
European Journal of Haematology|February 6, 2026
Targeting Ikaros and Aiolos: Next-Generation Cereblon E3 Ligase Modulators in MMMaria Eugenia Alvaro, Enrica Antonia Martino, Santino Caserta, et al.
Journal of Translational Medicine|August 15, 2025
Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclaxIlenia Valentino, Maria Eugenia Gallo Cantafio, Roberta Torcasio, et al.
Journal of Geriatric Oncology|March 9, 2025
Frailty predicts treatment-related toxicity and discontinuation in older adults with chronic lymphocytic leukemia treated with BTK and BCL-2 inhibitors: Findings from a prospective single-center cohort studyEnrica Antonia Martino, Ernesto Vigna, Paola De Luca, et al.
British Journal of Haematology|June 15, 2026
Minimal residual disease in diffuse large B-cell lymphoma after first-line therapy: Defining the continuum from metabolic remission to molecular clearanceSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
Genes, Chromosomes & Cancer|April 8, 2014
Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemiaMirjam Hoxha, Sonia Fabris, Luca Agnelli, et al.
European Journal of Haematology|December 26, 2025
Beyond PD-1: Mechanisms of Resistance to Checkpoint Blockade in Classical Hodgkin Lymphoma and Next-Generation Immune StrategiesSantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
European Journal of Haematology|February 3, 2026
Frontline Therapy in Diffuse Large B-Cell Lymphoma: Evolving Standards, Biological Insights, and Future DirectionsMamdouh Skafi, Santino Caserta, Ernesto Vigna, et al.
Pageof 32

Showing results (111-120 of 313) with videos related to

Sort By:
Pageof 32
Leukemia & Lymphoma|July 21, 2005
A gender-based score system predicts the clinical outcome of patients with early B-cell chronic lymphocytic leukemiaStefano Molica, Francesca R Mauro, Vincenzo Callea, et al.
Expert Review of Hematology|June 25, 2025
Maintenance therapy after ASCT in newly diagnosed multiple myeloma patients: single agent <i>versus</i> combination drugsEnrica Antonia Martino, Ernesto Vigna, Caterina Labanca, et al.
European Journal of Haematology|December 26, 2025
Chemotherapy-Sparing Strategies in Follicular Lymphoma: Emerging Targeted and Immune-Based ApproachesEnrica Antonia Martino, Santino Caserta, Mamdouh Skafi, et al.
European Journal of Haematology|February 6, 2026
Targeting Ikaros and Aiolos: Next-Generation Cereblon E3 Ligase Modulators in MMMaria Eugenia Alvaro, Enrica Antonia Martino, Santino Caserta, et al.
Journal of Translational Medicine|August 15, 2025
Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclaxIlenia Valentino, Maria Eugenia Gallo Cantafio, Roberta Torcasio, et al.
Journal of Geriatric Oncology|March 9, 2025
Frailty predicts treatment-related toxicity and discontinuation in older adults with chronic lymphocytic leukemia treated with BTK and BCL-2 inhibitors: Findings from a prospective single-center cohort studyEnrica Antonia Martino, Ernesto Vigna, Paola De Luca, et al.
British Journal of Haematology|June 15, 2026
Minimal residual disease in diffuse large B-cell lymphoma after first-line therapy: Defining the continuum from metabolic remission to molecular clearanceSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
Genes, Chromosomes & Cancer|April 8, 2014
Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemiaMirjam Hoxha, Sonia Fabris, Luca Agnelli, et al.
European Journal of Haematology|December 26, 2025
Beyond PD-1: Mechanisms of Resistance to Checkpoint Blockade in Classical Hodgkin Lymphoma and Next-Generation Immune StrategiesSantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
European Journal of Haematology|February 3, 2026
Frontline Therapy in Diffuse Large B-Cell Lymphoma: Evolving Standards, Biological Insights, and Future DirectionsMamdouh Skafi, Santino Caserta, Ernesto Vigna, et al.
Pageof 32